JN NOVA PHARMA INC: federal grants and contributions

Updated 12 October 2026 · Montreal|Montreal, QC · grants and contributions register · Ville-Marie–Le Sud-Ouest–Île-des-Soeurs

JN NOVA PHARMA INC: federal grants and contributions: 1 agreements; $4.6M value; 1 departments; 1 programs.

Assay record ASY-CA-0A5HC091KO · Cite as: Assay Systems, “JN NOVA PHARMA INC: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/jn-nova-pharma-inc/

$
1agreements
$4.6Mvalue
1departments
1programs

Largest agreements

COVID-19 Response: Development of novel COVID-19 Therapeutics utilizing Precision Medicine approach$4.6Mvalue2020start2023end

Development of a proprietary biological drug to block Coronavirus infectivity, whilst reducing induced pathology in symptomatic patients, permitting a faster recovery and avoiding multiple organ injuries

Departments

National Research Council Canada1agreements$4.6Mvalue1programs
  • Industrial Research Assistance Program – Contributions to Firms

All grants from National Research Council Canada

Years

20201agreements$4.6Mvalue1programs
  • Industrial Research Assistance Program – Contributions to Firms

Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.